In fact, five different breast cancer subtypes have been defined based on an immunohistochemical criteria that includes expression of estrogen (ER) and progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.